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a subtle dysfunction (expression) of the  FGFR1, SOS1 and 
RAF1  genes is involved in the development of the most com-
mon male reproductive tract disorder – unilateral or bilat-
eral cryptorchidism.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Cryptorchidism is the most frequent disorder of the 
urogenital tract in males. It is associated with important 
consequences in adulthood, such as infertility and tes-
ticular cancer. Androgens are key hormones involved in 
the completion of epididymo-testicular descent; there-
fore, impaired fetal androgen action can result in crypt-
orchidism. However, the underlying mechanism by 
which impaired androgen action produces ‘isolated’ 
cryptorchidism is still debatable  [1] . Furthermore, fibro-
blast growth factor receptor 1  (FGFR1) gene mutations 
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 Abstract 
 Background: In recent years, several genes were found to be 
involved in the process of epididymo-testicular descent, the 
most frequently cited ones include  INSL3 ,  HOXA10 ,  GNRHR , 
and  KAL1 . In this study, we analyzed the differences in gene 
expression profiles between cryptorchid and descended 
testes. In particular, we analyzed expression of all recently 
published genes known to be associated with undescended 
testis.  Patients and Methods: Twenty-two testicular biop-
sies from 18 boys were analyzed. We analyzed gene expres-
sion in 16 cryptorchid and 6 descended testes using Affy-
metrix Human Genome U133 Plus 2.0 GeneChips, and vali-
dated the results with qPCR.  Results: 3,688 transcripts were 
differentially expressed with an adjusted p value of  ! 0.05 
and a change of at least 1.5-fold. The list contained 1,866 
downregulated and 1,822 upregulated transcripts in the 
cryptorchid testes. A novel observation in our study was that 
the fibroblast growth factor receptor 1 gene  (FGFR1) and its 
mediators  SOS1 and  RAF1 were expressed less in undescend-
ed testes.  Conclusion: Based on our results, it is possible that 
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can cause both Kallmann syndrome and/or idiopathic 
hypogonadotropic hypogonadism, that are frequently
associated with cryptorchidism  [2] . Androgen-indepen-
dent events may also be responsible for testicular descent. 
Insulin-like factor 3 (INSL3), and its receptor, relaxin 
family peptide receptor 2 (RXFP2, also called LGR8, leu-
cine-rich repeat-containing GPCR, or GREAT, G-pro-
tein-coupled receptor), are possible regulators of testicu-
lar descent  that may be responsible for isolated cryptor-
chidism  [3] ; although mutations in the  INSL3  and  RXFP2 
 genes have rarely been associated with human cryptor-
chidism. Overall, the frequency of  INSL3  and  RXFP2  mu-
tations is 7/600 at birth (1.2%)  and 7/303 (2.3%) in persis-
tently cryptorchid  males, with a higher prevalence in bi-
lateral forms  (5/120, 4.2%) than in unilateral forms (1/183, 
0.5%)  [3, 4] . In addition, cryptorchidism may be associ-
ated with  a specific haplotype of the gene for estrogen 
receptor-  (ESR1), which mediates the estrogenic effects 
of environmental endocrine disrupters (EEDs). The ef-
fects of EEDs on testicular descent might depend on an 
individual’s genetic susceptibility  [5] . Epididymo-testic-
ular descent is a process where both testis and epididymis 
descend from dorsal abdominal wall into the scrotum 
and in humans this process is accomplished at birth. 
1–3% of epididymides and testes remain undescended 
and require treatment. Hormonal therapy generally 
around second birthday is successful in 20–60% depend-
ing on the undescended position of both organs. We hy-
pothesize that undescended testis has different gene ex-
pression pattern compared to descended one. Therefore, 
we analyzed gene expression with Affymetrix method for 
all the genes known to be involved in epididymo-testicu-
lar descent.
 Patients and Methods 
 Testicular Biopsies and Pooling of Patients 
 In our institutions, it is routine practice to perform testicular 
biopsy during surgery for undescended testis. We have found that 
testicular biopsy provides useful information about future semen 
quality and helps to identify patients with atypical spermatogonia 
or carcinoma in situ. Cryptorchid testis was defined as a testis 
localized outside the scrotum and incapable of being brought into 
a stable scrotal position. Th e age of the patients at surgery ranged 
from 10 months to 4.5 years.
 The contralateral descended testes from patients with testicu-
lar agenesis have been shown to have more Leydig and germ cells 
and a higher rate of transformation of Ad spermatogonia into 
spermatocytes than the contralateral descended testes of patients 
with unilateral cryptorchidism  [6] . Not all contralateral testes in 
patients with testicular agenesis are expected to have normal 
 histology and may require subsequent hormonal treatment  [6] . 
Therefore, we routinely biopsy these testes during the period of 
testicular fixation performed in order to prevent testicular tor-
sion. 
 Twenty-two testicular biopsies (as large as the size of a kernel of 
rice) from 20 boys were analyzed (16 testes from boys with crypt-
orchidism and 6 contralateral descended testes; 2 from boys with 
undescended testis and 4 from patients with testicular agenesis). 
All contralateral testes were selected for normal histology accord-
ing to age. The mean age of the patients at surgery was 3.2 years 
and for the controls 3.8 years. All patients had an extensive clinical 
examination, and we could not find any clinical signs of develop-
mental malformations or syndromes, none had hypospadias. In 
particular, no clinical sign for Kallmann syndrome was observed. 
Furthermore, all patients had normal thyroid screening and no 
features of hypopituitarism were discernible. Testicular position at 
surgery was one abdominal, one inguinal and 14 at tubercle.
 Biopsies were fixed in 3% glutaral dehyde and embedded in 
Epon. Semi-thin sections, 1   m thick, were examined by Zeiss 
Axioscope phase contrast and conventional light microscope 
(Plan-Apochromat 63 ! /1.40 oil).
 Photographs were performed with a Canon power-shot cam-
era. For each biopsy, at least 200 tubular cross-sections were eval-
uated. Immediately following biopsy, one half of each biopsy sam-
ple was collected for RNA isolation and GeneChip hybridization, 
and was stored in cold 1 ! phosphate-buffered saline (PBS). The 
tissue was then filtered through 100-nm nylon gauze. Fractions 
were collected, washed three times in 1 ! PBS, and snap-frozen 
in liquid nitrogen prior to storage at –80   °   C. An aliquot of each 
fraction was fixed in 1 ! PBS containing 1% formaldehyde (Polio, 
France) and 1% fetal calf serum (Eurabbie, France) and analyzed 
by DNA flow cytometry to determine its relative DNA content. 
Cell pellets and tissues were sheared in RLT buffer (Qiagen) sup-
plemented with 1%   -mercaptoethanol and further processed us-
ing a Qiashredder (Qiagen). The suspension was centrifuged for 
2 min at maximum speed and the clarified lysate was stored at 
–80   °   C. Total RNA isolation was performed using RNeasy Mini-
Spin columns (Qiagen) according to standard protocols. RNA 
quality was monitored using RNA Nano 6000 Chips and the 2100 
BioAnalyzer (Agilent). cRNA synthesis, human U133 plus 2.0 
GeneChip hybridization and raw data recovery were carried
out as published previously  [7] . Raw data files are available at the 
EBI ArrayExpress repository  [8] via the accession numbers 
ETABM-130 and E-TABM-174 and GEO.
 Statistical Analysis and Interpretation of Microarray Data 
 Data analysis and gene filtering were performed using R/Bio-
conductor  [9] . Signal condensation was performed using only the 
RMA from the Bioconductor Affy package. Differentially ex-
pressed genes were indentified using the empirical Bayes method 
(Ftest) implemented in the LIMMA package and adjusted with 
the false discovery rate method  [10] . We selected those probe sets 
with a Log2 average contrast signal of at least 5, an adjusted
p value  ! 0.05 and an absolute Log2 fold change of  1 0.585 (1.5-
fold in linear space). Hierarchical clustering and visualization 
were performed in R. 
 Quantitative Real-Time PCR 
 Quantitative real-time PCR (qRT-PCR) was performed using 
a Corbett Research RG-6000 instrument. cDNAs were synthe-
sized with Reverse Transcriptase – Core Kit (Eurogentec, cat.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
4/
20
17
 4
:1
3:
27
 P
M
 Decreased Expression of  FGFR1 ,  SOS1 , 
 RAF1 Genes in Cryptorchidism  
Urol Int 2010;84:353–361 355
No. RT-RTCK-03) using random primers. Real-time PCR runs 
were performed using SyBr Fast Kit (Kapa Biosystems, cat. No. 
KK4602) with each gene-specific primer at 200 n M final concen-
tration in a total volume of 17.5   l. Length waves of source and 
detection were set at 470 and 510 nm, respectively. Gain was set at 
8.33. PCR program was set as follows: 95  °  C for 60 s – 45 ! (95  °  C 
for 3 s, 60   °   C for 10 s, 72   °   C for 4 s) followed by a melting curve 
analysis (65–95  °  C, rising by 0.65  °  C in each step) to attest ampli-
fication specificity. Threshold cycles (crossing point) were deter-
mined using Rotor-Gene software version 6.1. Good PCR effi-
ciency was checked by performing a dilution series of the cDNA. 
Minus RT controls were performed for each sample studied. 
Threshold cycles (crossing point) were determined using Rotor-
Gene software version 6.1. Expression levels were normalized to 
TFRC1 and GAPDH using a geometric mean of their level of ex-
pression. Those genes were selected because they showed mini-
mum variation between individual samples (both on microarrays 
and by qPCR). Fold differences were calculated using the delta-
delta Ct method.
 Antibody Validation 
 We wanted to determine whether greater transcript expres-
sion corresponded to greater protein expression. Immunoperoxi-
dase histochemistry, although not a quantitative method, is cur-
rently the only practical way to detect proteins in small fixed tis-
sue samples. We employed ten antibodies to proteins known to be 
involved in the reproductive hormonal axis.
 For immunohistochemical analysis, Epon was removed from 
the tissue sections. The sections were treated with 2% bovine se-
rum albumin to reduce non-specific binding and then incubated 
with primary antibody overnight at 4  °  C. All samples were washed 
with PBS between incubations. We validated ten antibodies ( ta-
ble 1 ).
 Secondary antibodies, labeled with polymer-horseradish per-
oxidase [goat polyclonal anti-rabbit IgG, mouse IgG and IgM 
(prediluted; ab2891); Abcam, Cambridge, UK] were used to detect 
binding of the primary antibody. The chromogenic reaction was 
developed by adding a freshly prepared solution of 3,3-diamino-
benzidine solution (DAB + chromogen; DAKO). The DAB reac-
tion was terminated by washing in TRIS-buffered saline (TBS 
0.05  M and 0.85  M NaCl, ph 7.6). To visualize the histology of tes-
ticular cells, the samples were counterstained with toluidine blue. 
Antibody binding was indicated by a brown precipitate. Different 
cell types were identified on the basis of their nuclear morphology 
and position within the developing gonad. Immunohistochemis-
try experiments were performed at least twice on at least 4 patients 
from each group, and only those with identical results between 
experiments for each sample were considered acceptable. Con-
trols for nonspecific binding of the secondary antibody were per-
formed in all experiments by omitting the primary antibody; 
these consistently yielded no signal within the seminiferous epi-
thelium or the interstitial space. The interstitial staining observed 
in the presence of the primary antibody was considered to be non-
specific because it was not associated with, or localized within, a 
particular cell type. However, staining of interstitial cells was re-
corded. Experimental design, biomaterials and treatments, re-
porters, staining, imaging data, and image characterization were 
performed in compliance with the minimum information speci-
fication for immunohistochemistry experiments  [11] .
 Ethical Considerations and Approval 
 In accordance with the Declaration of Helsinki, the Institu-
tional Review Board of Kindertagesklinik Liestal approved all as-
pects of this study. Approval was provided for research involving 
the use of material (data records or specimens) that had original-
ly been collected for non-research purposes.
 Results 
 The total RNA and cRNA samples were of high qual-
ity, the signal intensity distributions were similar and 
were within the normal range.  Figure 1 shows the heat 
map resulting from the visualized signal intensities, 3,688 
transcripts were differentially expressed in the cryptor-
chid and descended testes after statistical filtering (fold 
change  1 1.5, adjusted p value  ! 0.05). This gene list was 
composed of 1,822 elevated and 1,866 decreased tran-
scripts in the cryptorchid testes.
Table 1. Antibodies utilized for immunohistochemical validation
Antibody Animal Code/lot Type Source
DDX25 goat SC-51269/A2108 polyclonal Santa-Cruz
EGR1 mouse AB54966/509443 monoclonal Abcam
EGR4 goat SC-19868/JU306 polyclonal Santa-Cruz
CBL mouse SC-1651/BO206 monoclonal Santa-Cruz
ACVR1B1 rabbit AB71539/603652 polyclonal Abcam
ALDH1A2 mouse SC-22591/1008 monoclonal Santa-Cruz
KLF4 rabbit AB26648/641290 polyclonal Abcam
MAGEA4 goat SC-28484/62006 polyclonal Santa-Cruz
COL4A3 goat SC-18177/L1404 polyclonal Santa-Cruz
FGFR1 mouse AB823 monoclonal Abcam
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 Our particular interest was to investigate the expres-
sion profiles of genes that had previously been shown
to be associated with cryptorchidism, namely:  INSL3, 
RXFP2/LGR8/GREAT, NR4A1, NR5A1, CYP19, NROB1/
DAX1/AHC, KAL1, GNRHR, PROK2, LHB, ESR1, SOX2, 
 GPR54,  and HOXA10 ( table 2 ). We found  INSL3 was ex-
pressed equally in descended and undescended testes. 
Furthermore, analysis of the expression pattern of the 
gene for the INSL3 receptor,  RXFP2 , also called  LGR8 or 
 GREAT , showed no differences between the two groups 
studied ( table 2 ). Low, not significantly different expres-
sion was found in both groups for  CYP19A1 , GNRHR , 
PROK2 , SOX2, KISS1R ( GPR54 ), and  HOXA10 ( table 2 ). 
No differences were observed in the signaling intensity of 
 NR4A1 ,  NR5A1 ,  NROB1/DAX1/AHC ,  KAL1 ,  LHB , and 
 ESR1 ( table 2 ). Our main finding was that cryptorchid 
testis displayed reduced expression of  FGFR1 , as well as 
 RAF1 and  SOS1 , known to be part of its signaling path-
way ( table 3 ).
 Immunohistochemical and qRT-PCR Validation 
 Immunoperoxidase histochemistry, although not a 
quantitative method, is currently the only practical way 
to detect proteins in small fixed tissue samples. To deter-
mine whether transcript expression corresponded to pro-
tein expression, several antibodies were employed and 
the histological sections of both groups were compared. 
The proteins EGR4, MAGE4, ALDH1, and COL4A3 were 
expressed in the spermatogonia of both groups ( fig. 2 ). 
Identical cytoplasmic localization was found for all other 
proteins analyzed. In addition to its expression in germ 
and Leydig cells, CBL was expressed in Sertoli cells. Fgfr1 
expression was observed in cytoplasm of the germ and 
Leydig cells ( fig. 3 ). We validated our microarray data by 
qRT-PCR on four genes that showed significant expres-
sion changes, all of which showed high correlation in the 
obtained transcriptional profiles ( fig. 4 ).
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 Fig. 1. Heat map showing gene expression 
levels of cryptorchid and descended tes-
tes. Red represents upregulated and green 
downregulated genes. 
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 Discussion 
 The hypothalamo-pituitary-gonadal axis (HPG) regu-
lates the development and the endocrine and reproductive 
functions of the gonads throughout all phases of life. Sev-
eral animal models of hypogonadotropic hypogonadism 
are associated with cryptorchidism. (1) HPG male mice 
lacking  GnRH  are cryptorchid, but have a normal guber-
naculum, and their testes develop and descend normally 
if treated with gonadotropins  [12] . (2) Pask et al. [13] re-
ported a  GnRH receptor (GnRHr) gene loss-of-function 
mutation in male mice that caused hypogonadotropic hy-
pogonadism during  N- ethyl- N -nitrosourea mutagenesis 
screening. Affected males had a micropenis, undescended 
testes, and were infertile. (3) Luteinizing hormone recep-
tor (LHR) knockout male mice showed undescended tes-
tes, small testis, underdeveloped scrotum, small penis, and 
arrested spermatogenesis  [14, 15] . Cryptorchidism in  LHR 
knockouts was caused by developmental defects of guber-
naculum because of testosterone deficiency, and testoster-
one replacement therapy reversed all morphologic and 
gene expression changes except  INSL3 , suggesting that tes-
tosterone secreted by Leydig cells facilitates the comple-
tion of testicular descent  [15] . These knockout male mice 
had inguinoscrotal testes, suggesting the HPG axis is dis-
tributed in the inguinoscrotal phase of testis descent  [15] .
 The FGFR1 signaling pathway regulates cell prolifera-
tion, migration, differentiation, and survival; according-
ly, it is essential for various phases of human development 
 [16] . Mutations of the  FGFR1 gene have been described in 
cases of idiopathic hypogonadotropic hypogonadism 
with functioning olfactory bulb and normal sense of 
smell  [2, 17] . Pitteloud et al.  [17] described that FGFR1 
was critical not only for the migration of GnRH neurons 
across the olfactory tracts, but also demonstrated that an 
entirely different mechanism must exist for the failure of 
GnRH in those cases with normal olfactory bulbs, tracks, 
and senses of smell  [18] . This phenotypic complexity sug-
gested  FGFR1  mutations, in addition to presumably play-
ing a critical role in GnRH neuronal maturation, may be 
associated with neuronal survival and possibly apoptosis 
in normosmic idiopathic hypogonadotropic hypogonad-
ism patients with  FGFR1 mutations  [19] . 
 Leydig cell atrophy was observed in all undescended 
testes ( fig. 3 ,  4 ). This atrophy is a consequence of hypo-
gonadotropic hypogonadism  [20, 21] . Furthermore, low 
number of germ cells and particularly impaired germ cell 
differentiation is a further evidence of impaired gonadal 
maturation after birth, also denominated mini-puberty 
( fig. 3 ,  4 )  [20, 21] .
Table 2. Expression values of 16 genes involved in the process of 
epididymo-testicular descent
Gene symbol Probe set ID  Median value
cry ptorchid descended
INSL3 1553594_a_at 9.55051762 9.44872353
214400_at 8.96849613 8.59509113
214572_s_at 10.2362787 9.98199254
RXFP2 1553326_at 2.51231563 2.49421155
NR4A1 202340_x_at 6.17169726 6.35677944
210226_at 5.44048775 5.47187537
211143_x_at 4.95417354 4.73797538
NR5A1 210333_at 5.01168715 4.50725008
CYP19A1 1554296_at 2.21019698 2.18203546
1560295_at 4.01860367 4.17272721
203475_at 2.86980186 2.8237
240705_at 3.50708023 3.40659826
240863_at 2.17002677 2.15669923
NR0B1/DAX1/AHC 206644_at 4.10496977 3.50749603
206645_s_at 7.52022053 6.39801481
KAL1 205206_at 9.49971782 9.25717797
229853_at 3.59942868 3.62896527
GNRHR 211522_s_at 3.75227569 3.08793908
211523_at 2.70213402 2.64301747
216341_s_at 4.65314009 4.57382752
PROK2 232629_at 3.89249056 3.86664277
LHB 214471_x_at 5.5269635 5.29761942
ESR1 205225_at 5.69431462 5.20809283
211233_x_at 4.49075955 4.24512071
211234_x_at 5.07846696 5.04469176
211235_s_at 4.9183534 4.86495925
211627_x_at 2.83001718 2.64012202
215551_at 2.99613765 3.22418077
215552_s_at 3.30187431 3.28320076
217163_at 3.69396359 3.57172417
217190_x_at 3.38580973 3.07410043
SOX2 213721_at 3.81689992 3.66312997
213722_at 3.50821965 3.45568233
214178_s_at 3.88332337 4.02062008
228038_at 2.59151923 2.5668031
KISS1R (GPR54) 242517_at 3.27949914 2.94987107
HOXA10 213147_at 4.57090229 4.48878348
213150_at 3.63283876 3.14758548
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Table 3. FGFBP2, FGFR1, RAF1, SOS1 gene expression values of cryptorchid and descended testes
Gene symbol Probe set ID  Median value Adjusted
p value
logFC
c ryptorchid descended
FGFBP2 223836_at 7.61253 6.25911 0.04170411 1.52937555
FGFR1 215404_x_at 6.06631 7.17697 0.00848763 –1.02287333
FGFR1 222164_at 5.54525 6.31121 0.01670167 –0.72301012
RAF1 1557675_at 6.72658 7.61658 0.0399879 –0.79031992
SOS1 230337_at 7.20646 8.32818 0.03287241 –0.92108813
 
a b
c d
 Fig. 2. Gene validation at protein level.  a MAGE4.  b EGR4.  c ALDH1A2.  d COL4A3. All four antibodies were 
found in the cytoplasm of germ cells stained brown (arrow). Contra-staining was performed with toluidine blue. 
No EGR4 in Sertoli cells or peritubular connective tissue. Atrophic juvenile Leydig cell (double arrow). 
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 Fig. 4. Correlation of microarray data
with data obtained by qRT-PCR on four 
genes that displayed significant expres-
sion cha nges showing a high correlation
in the obtained transcriptional profiles. 
The y-axis is z-normalized Log2 expres-
sion (array) and 2-normalized QT value 
(QPCR); x-axis shows biopsy file names. 
 Fig. 3. FGFR1 antibody found in the cyto-
plasm of germ cells stained brown, as well 
as in atrophic Leydig cells (arrows) and
peritubular connective tissue. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
4/
20
17
 4
:1
3:
27
 P
M
 Hadziselimovic  /de Geyter  /Demougin  /
Oakeley  /Hadziselimovic  
 
Urol Int 2010;84:353–361 360
 Furthermore, FGFR1 affects the proliferation and mi-
gration of vascular smooth muscle cells  [22] and is in-
volved in myoblast proliferation and differentiation  [23] . 
Inhibited muscle development was observed in the epi-
didymis and scrotal anlage in  INSL3 mutant mice  [24–
26] . Reduced expression of  FGFR1 has not been described 
before in association with isolated cryptorchidism. Nev-
ertheless, mediators of the FGFR1 signaling pathway, 
SOS1 and RAF1, have been associated with leopard syn-
drome and Noonan syndrome  [27] , syndromes that in-
clude cryptorchidism. Theoretically, the reduced gene 
expression of  FGFR1 and its mediators,  SOS1 and  RAF1 , 
could affect muscle development and, therefore, cause 
crypto-epididymis.
 Recently, Ferlin et al.  [3] determined the frequency of 
genetic alterations such as karyotype anomalies and 
 INSL3 ,  LGR8 / GREAT , and  AR  gene mutations in cryptor-
chidism in their large study. They reported that the over-
all frequency of genetic alterations was significantly 
higher in boys with cryptorchidism (5.3%) than in con-
trols (0.3%). As a result, the odds ratio for the association 
of cryptorchidism with genetic alterations was 16.7, indi-
cating a significant association between cryptorchidism 
and genetic alterations.  In more than 2,000 patients and 
controls analyzed to date, the T222P  RXFP2 mutation is 
the only mutation strongly associated with the mutant 
phenotype. INSL3 production is also related to LH  [2] ; 
although INSL3 apparently has a great effect in mouse 
models, it remains unclear what role it plays in the tes-
ticular descent of humans. Analyses of mutations of 
 INSL3 , as well as  LGR8/GREAT genes, in boys with either 
unilateral or bilateral cryptorchidism revealed only a 
small percentage to have sequence changes of functional 
significance. Our examinations showed no differences in 
the gene expression profiles of  INSL3 or  LGR8 between 
subjects with descended and cryptorchid testes. In all of 
the boys we examined, the transabdominal phase had 
been completed. This could explain why we could not 
find a difference in expression of  INSL3 .
 We could not find significant differences between de-
scended and undescended testis with respect to the 14 
genes described as being involved in cryptorchidism de-
velopment. This may be because these genes were found 
associated either with pronounced androgen deficiency 
( NR5A1 ,  NR4A1 , and  CYP19 ) or with classical hypogo-
nadotropic hypogonadism ( GNRHR ,  KAL1 ,  LHB , and 
 PROK2 ).
 In conclusion, mutations of the  FGFR1 gene induce 
idiopathic hypogonadotropic hypogonadism. A subtle 
dysfunction of the  FGFR1 gene, observed here in crypt-
orchid testes, may be responsible for unilateral or bilat-
eral epididymo-testicular arrest along the descent path 
into the scrotum. 
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